Literature DB >> 6492779

Identification of nonviable muscle in electric burns with nitroblue tetrazolium.

J L Hunt, E L Heck.   

Abstract

Both experimental and clinical evaluation of nitroblue tetrazolium (NBT) as a method of identifying ischemic and necrotic muscle is described. Colorless NBT was reduced to a blue formazin by viable muscle but remained colorless in necrotic muscle. Muscle samples were rated for viability on a scale of 0-100% based on the relative amount of muscle sample that reduced NBT. There was good correlation between gross appearance, distribution of staining, and histologic findings in all nonviable experimental and clinical muscle specimens. All tissue that reacted with NBT proved to be viable histologically. Metabolically active or viable muscle fibers are rich in respiratory enzymes (dehydrogenases). The loss of dehydrogenase activity from ischemic or necrotic muscle can be detected by NBT reduction capacity. NBT technique identified nonviable tissue, clearly showed the even distribution of muscle damage characteristic of electric burns, was useful in defining ischemic muscle prior to obvious necrosis, and was a rapid, simple, and reliable semiquantitative test that can be used intraoperatively.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6492779     DOI: 10.1016/0022-4804(84)90202-6

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  3 in total

1.  The 'nothing dehydrogenase' reaction and the detection of ischaemic damage.

Authors:  W M Frederiks; F Marx; G L Myagkaya
Journal:  Histochem J       Date:  1989 Sep-Oct

2.  Local cooling provides muscle flaps protection from ischemia-reperfusion injury in the event of venous occlusion during the early reperfusion period.

Authors:  Ryan S Diederich; Arian Mowlavi; Garth Meldrum; Brad Medling; Reuben A Bueno; Michael W Neumeister
Journal:  Hand (N Y)       Date:  2008-09-24

3.  High-voltage electrical injury: a role for mandatory exploration of deep muscle compartments.

Authors:  T A d'Amato; I B Kaplan; L D Britt
Journal:  J Natl Med Assoc       Date:  1994-07       Impact factor: 1.798

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.